Jean Saint-Germain

Title: Jean Saint-Germain: Innovator in Pharmaceutical Chemistry

Introduction

Jean Saint-Germain is a notable inventor based in Sisteron, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of polymorphic forms of clopidogrel hydrogen sulfate. With a total of 2 patents to his name, his work has implications for the medical industry.

Latest Patents

Saint-Germain's latest patents include the "Polymorphic form of clopidogrel hydrogen sulphate," which describes a novel orthorhombic polymorph of clopidogrel hydrogen sulfate or hydrogen sulfate of methyl (+)-(S)-α-(2-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-5-acetate and a process for its preparation. Another patent, "Polymorphic clopidogrel hydrogenesulphate form," also focuses on a similar orthorhombic polymorph and its preparation process.

Career Highlights

Jean Saint-Germain is associated with Sanofi-Synthelabo, a leading global pharmaceutical company. His work at the company has allowed him to explore innovative solutions in drug formulation and development.

Collaborations

Throughout his career, Saint-Germain has collaborated with esteemed colleagues such as André Bousquet and Bertrand Castro. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jean Saint-Germain stands out as an influential inventor in the pharmaceutical sector, with his innovative work on clopidogrel hydrogen sulfate. His contributions continue to impact the field and enhance drug development processes.